Allyl-, butyl- and phenylethyl-isothiocyanate modulate akt-mtor and cyclin-cdk signaling in gemcitabine- and cisplatin-resistant bladder cancer cell lines

HIGHLIGHTS

• who: Jochen Rutz and collaborators from the Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany have published the research: Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt-mTOR and Cyclin-CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines, in the Journal: (JOURNAL) of 19/08/2022
• what: This study investigated the potential of the natural isothiocyanates (ITCs) (AITC) (BITC) and phenylethylisothiocyanate (PEITC) to suppress growth and proliferation of and bladder cancer cells lines.
• future: Investigations are however necessary to explore the full potential of the ITCs with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.